Literature DB >> 8879384

Chemotherapy of biliary tract cancer with mitomycin-C and 5-fluorouracil biologically modulated by folinic acid. A phase II study.

A Polyzos, G Nikou, A Giannopoulos, A Toskas, N Kalahanis, J Papargyriou, P Michail, A Papachristodoulou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8879384     DOI： 10.1093/oxfordjournals.annonc.a010687

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer.

Authors:  Nikolas Tsavaris; Christos Kosmas; Panagiotis Gouveris; Kostadinos Gennatas; Aris Polyzos; Despina Mouratidou; Heracles Tsipras; Helias Margaris; George Papastratis; Evanthia Tzima; Nikitas Papadoniou; Gavrilos Karatzas; Efstathios Papalambros
Journal:  Invest New Drugs       Date:  2004-04       Impact factor: 3.850

2.  Pemetrexed and gemcitabine for biliary tract and gallbladder carcinomas: a North Central Cancer Treatment Group (NCCTG) phase I and II Trial, N9943.

Authors:  Steven R Alberts; Jonathan R Sande; Nathan R Foster; Fernando J Quevedo; Robert R McWilliams; John W Kugler; Tom R Fitch; Anthony J Jaslowski
Journal:  J Gastrointest Cancer       Date:  2008-11-21

3.  Phase II study of S-1 in patients with advanced biliary tract cancer.

Authors:  H Ueno; T Okusaka; M Ikeda; Y Takezako; C Morizane
Journal:  Br J Cancer       Date:  2004-11-15       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.